The accuracy of the Surecell Chlamydia Test Kit (Kodak Clinical Products, Rochester, N.Y.) in detecting neonatal conjunctival infection caused by Chlamydia trachomatis was determined by comparison of this enzyme immunoassay with the isolation of C. trachomatis in tissue culture. Kodak Surecell is a rapid monoclonal antibody-based membrane capture enzyme immunoassay which can be processed in the office of a physician. The sensitivity and specificity compared to culture in detecting C. trachomatis in conjunctival specimens from infants with conjunctivitis were 93 and 96%, respectively. The test does not require specialized equipment or trained personnel and would be ideal for physicians who see low numbers of infants with possible chlamydial conjunctivitis in their offices.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC267949PMC
http://dx.doi.org/10.1128/jcm.28.6.1441-1442.1990DOI Listing

Publication Analysis

Top Keywords

kodak surecell
8
surecell chlamydia
8
chlamydia test
8
test kit
8
chlamydial conjunctivitis
8
enzyme immunoassay
8
comparison kodak
4
kit culture
4
culture diagnosis
4
diagnosis chlamydial
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!